Quantcast

Daily Traders Edge

Fund manager with 20% gain this year sees good times ahead as FDA becomes ‘more accommodating’

July 13
09:04 2017

Ziad Bakri, manager of the T. Rowe Price Health Sciences Fund, looks for three main themes in his stock picks.

Related Articles

Newsletter Signup

Sign up for our free newsletter